Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients

G. Cannella, G. La Canna, M. Sandrini, M. Gaggiotti, G. Nordio, E. Movilli, S. Mombelloni, O. Visioli, R. Maiorca

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

To clarify the role of chronic anaemia in the pathogenesis of the left ventricular hypertrophy (LVH) of chronic uraemia, nine normotensive dialysed patients were studied before and 3 and 6 months after start of intravenous treatment with recombinant human erythropoietin (rHuEpo). M-Mode echocardiographic estimations of left ventricular mass indices (LVMi) and plasma noradrenaline determinations were made at 3 and 6 months, and total blood volume (TBV) only at 6 months. Resting haemoglobin values were 5.9±1.3 (SD) g/dl, increased within 3 months to 10.2±1.2 (P2 body surface area (b.s.a.) and decreased significantly (P

Original languageEnglish
Pages (from-to)31-37
Number of pages7
JournalNephrology Dialysis Transplantation
Volume6
Issue number1
Publication statusPublished - 1991

Fingerprint

Uremia
Body Surface Area
Left Ventricular Hypertrophy
Erythropoietin
Blood Volume
Anemia
Norepinephrine
Hemoglobins
Therapeutics

Keywords

  • Chronic anaemia
  • Chronic uraemia
  • Left ventricular hypertrophy
  • Recombinant human erythropoietin

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. / Cannella, G.; La Canna, G.; Sandrini, M.; Gaggiotti, M.; Nordio, G.; Movilli, E.; Mombelloni, S.; Visioli, O.; Maiorca, R.

In: Nephrology Dialysis Transplantation, Vol. 6, No. 1, 1991, p. 31-37.

Research output: Contribution to journalArticle

Cannella, G, La Canna, G, Sandrini, M, Gaggiotti, M, Nordio, G, Movilli, E, Mombelloni, S, Visioli, O & Maiorca, R 1991, 'Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients', Nephrology Dialysis Transplantation, vol. 6, no. 1, pp. 31-37.
Cannella, G. ; La Canna, G. ; Sandrini, M. ; Gaggiotti, M. ; Nordio, G. ; Movilli, E. ; Mombelloni, S. ; Visioli, O. ; Maiorca, R. / Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. In: Nephrology Dialysis Transplantation. 1991 ; Vol. 6, No. 1. pp. 31-37.
@article{aaf6618c597c4fa09559f39c4f7e3b93,
title = "Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients",
abstract = "To clarify the role of chronic anaemia in the pathogenesis of the left ventricular hypertrophy (LVH) of chronic uraemia, nine normotensive dialysed patients were studied before and 3 and 6 months after start of intravenous treatment with recombinant human erythropoietin (rHuEpo). M-Mode echocardiographic estimations of left ventricular mass indices (LVMi) and plasma noradrenaline determinations were made at 3 and 6 months, and total blood volume (TBV) only at 6 months. Resting haemoglobin values were 5.9±1.3 (SD) g/dl, increased within 3 months to 10.2±1.2 (P2 body surface area (b.s.a.) and decreased significantly (P",
keywords = "Chronic anaemia, Chronic uraemia, Left ventricular hypertrophy, Recombinant human erythropoietin",
author = "G. Cannella and {La Canna}, G. and M. Sandrini and M. Gaggiotti and G. Nordio and E. Movilli and S. Mombelloni and O. Visioli and R. Maiorca",
year = "1991",
language = "English",
volume = "6",
pages = "31--37",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients

AU - Cannella, G.

AU - La Canna, G.

AU - Sandrini, M.

AU - Gaggiotti, M.

AU - Nordio, G.

AU - Movilli, E.

AU - Mombelloni, S.

AU - Visioli, O.

AU - Maiorca, R.

PY - 1991

Y1 - 1991

N2 - To clarify the role of chronic anaemia in the pathogenesis of the left ventricular hypertrophy (LVH) of chronic uraemia, nine normotensive dialysed patients were studied before and 3 and 6 months after start of intravenous treatment with recombinant human erythropoietin (rHuEpo). M-Mode echocardiographic estimations of left ventricular mass indices (LVMi) and plasma noradrenaline determinations were made at 3 and 6 months, and total blood volume (TBV) only at 6 months. Resting haemoglobin values were 5.9±1.3 (SD) g/dl, increased within 3 months to 10.2±1.2 (P2 body surface area (b.s.a.) and decreased significantly (P

AB - To clarify the role of chronic anaemia in the pathogenesis of the left ventricular hypertrophy (LVH) of chronic uraemia, nine normotensive dialysed patients were studied before and 3 and 6 months after start of intravenous treatment with recombinant human erythropoietin (rHuEpo). M-Mode echocardiographic estimations of left ventricular mass indices (LVMi) and plasma noradrenaline determinations were made at 3 and 6 months, and total blood volume (TBV) only at 6 months. Resting haemoglobin values were 5.9±1.3 (SD) g/dl, increased within 3 months to 10.2±1.2 (P2 body surface area (b.s.a.) and decreased significantly (P

KW - Chronic anaemia

KW - Chronic uraemia

KW - Left ventricular hypertrophy

KW - Recombinant human erythropoietin

UR - http://www.scopus.com/inward/record.url?scp=0026030345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026030345&partnerID=8YFLogxK

M3 - Article

C2 - 1829146

AN - SCOPUS:0026030345

VL - 6

SP - 31

EP - 37

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 1

ER -